Skip to content

Navigation

  • Map
  • Episodes
  • Articles
  • Advertise
  • About Us
  • Subscribe Free

Social

YouTube Spotify Apple Podcasts
  • Map
  • Episodes
  • Articles
  • Advertise
  • About Us
Subscribe Free

Tag: argenx

Argenx is Europe’s most valuable biotech company in 2025. With one approved drug on the market and several more in the pipeline, Argenx is leading the charge in immunology and is addressing significant unmet medical needs.

How Europe could have more Biotech Champions like Argenx

How Europe could have more Biotech Champions like Argenx

For decades, the narrative of European biotech has been one of “innovation flight”: brilliant science...
Philip Hemme
Philip Hemme
argenxbiotech investing
• Apr 17, 2026
The 25 Most Valuable Biotech Companies in Europe in 2025

The 25 Most Valuable Biotech Companies in Europe in 2025

The biotech industry in Europe is booming, with companies making groundbreaking medical advances, from oncology...
Philip Hemme
Philip Hemme
argenxAscendis Pharma
• May 19, 2025

Never Miss a New Episode 💌

Trusted by 2500+ biopharma professionals from top companies like argenx, Roche, and Forbion. No spam, no noise.

Watch & Subscribe

Flot.bio on Youtube Flot.bio on Spotify Flot.bio on Apple Podcasts
Flot.bio
  • Map
  • Episodes
  • Articles
  • About Us
  • Donate
  • Media Kit
  • Subscribe Free

Contact us via Katherine: hi@flot.bio

Follow Us:

Latest Episode:
Billionaire wild bets on Consumer Biotech, GLP-1s, and psychedelics | Christian Angermayer | E61
Latest Article:
Consumer Biotech’s Next Wave: Muscle, Sex, and Psychedelics
Flot.bio © 2026
Made with ❤ in Europe 🇪🇺
  • Imprint
  • Privacy Policy